Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press Series of Journals Center for Evidence-Based and Translational Medicine of Wuhan University

The title
  • The title
  • The keywords
  • The author
Submit中文版

HomeArticlesVol 31,2021 No.6Detail

The expression regulation and clinical significance of miRNA in esophageal cancer

Published on Nov. 16, 2021Total Views: 14532 timesTotal Downloads: 4274 timesDownloadMobile

Author: Ya-Nan LI Li ZHANG Zhi-Fan XIONG

Affiliation: Department of Gastroenterology, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430077, China

Keywords: Esophageal cancer miRNA Biomarker Expression regulation

DOI: 10.12173/j.issn.1004-5511.202012070

Reference: Li YN, Zhang L, Xiong ZF. The expression regulation and clinical significance of miRNA in esophageal cancer[J]. Yixue Xinzhi Zazhi, 2021, 31(6): 455-459. DOI: 10.12173/j.issn.1004-5511.202012070.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

China is one of the countries with the high incidence of esophageal cancer in the world. Hence it is of great significance to explore the pathogenesis of esophageal cancer and screen out biomarkers for diagnosis and prognosis as well as therapeutic targets. As a novel biomarker, microRNA (miRNA) has been widely studied in esophageal cancer. In this paper, the expression regulation mechanism of miRNA in esophageal cancer and its role in clinical diagnosis, treatment and prognosis of esophageal cancer are reviewed.

Full-text
Please download the PDF version to read the full text: download
References

1. Zhao X, Lim F. Lifestyle risk factors in esophageal cancer: an integrative review[J]. Crit Care Nurs Q, 2020, 43(1): 86-98. DOI: 10.1097/CNQ.0000000000000295.

2. Sun H, Wang L, Zhao Q, et al. Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma[J]. Cancer Biomark, 2019, 25(4): 381-387. DOI: 10.3233/CBM-190007.

3. Bai H, Wu S. miR-451: a novel biomarker and potential therapeutic target for cancer[J]. Onco Targets Ther, 2019, 12: 11069-11082. DOI: 10.2147/OTT.S230963.

4. Pan Z, Lin J, Wu D, et al. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma[J]. Aging (Al-bany NY), 2019, 11(24): 11937-11954. DOI: 10.18632/aging.102519.

5. Shi Y, Guo Z, Fang N, et al. Hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma[J]. Biomed Pharma-cother, 2019, 117: 109151.DOI: 10.1016/j.biopha.2019.109151.

6. Hou Y, Liu H, Pan W. Knockdown of circ_0003340 induces cell apoptosis, inhibits invasion and prolifer-ation through miR-564/TPX2 in esophageal cancer cells[J]. Exp Cell Res, 2020, 394(2): 112142. DOI: 10.1016/j.yexcr. 2020.112142.

7. Lan X, Liu X, Sun J, et al. CircRAD23B facilitates proliferation and invasion of esophageal cancer cells by sponging miR-5095[J].  Biochem Biophys Res Commun, 2019, 516(2): 357-364. DOI: 10.1016/j.bbrc.2019.06.044.

8. 赵志国, 张力平. miRNA和lncRNA相互作用与恶性肿瘤相关性的研究进展[J]. 现代肿瘤医学, 2018, 26(18): 2991-2994. DOI: 10.3969/j.issn.1672- 4992.2018.18.040. [Zhao ZG, Zhang LP. Advancements of interac-tion between miRNA and lncRNA on malignant tumor[J]. Journal of Modern Oncology, 2018, 26(18): 2991-2994.]

9. Li Z, Qin X, Bian W, et al. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis[J]. J Exp Clin Cancer Res, 2019, 38(1): 1-13. DOI: 10.1186/s13046-019-1473-8.

10.  Shen SN, Li K, Liu Y, et al. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcino-ma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1[J]. Mol Oncol, 2019, 13(12): 2554-2573. DOI: 10.1002/1878-0261.12555.

11.  Wang AH, Tan P, Zhuang Y, et al. Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204[J]. J Cell Mol Med, 2019, 23(10): 6595-6610. DOI: 10.1111/jcmm.14502.

12.  Li F, Zhou X, Chen M, et al. Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior[J]. Exp Mol Pathol, 2020, 116: 104491. DOI: 10.1016/j.yexmp.2020.104491.

13.  Cui Y, Zhang C, Lian H, et al. LncRNA linc00460 sponges miR-1224-5p to promote esophageal cancer metastatic potential and epithelial-mesenchymal transition[J]. Pathol Res Pract, 2020, 216(7): 153026. DOI: 10.1016/j.prp.2020.153026.

14.  Yu L, Todd NW, Xing L, et al. Early detection of lung adenocarcinoma in sputum by a panel of mi-croRNA markers[J]. Int J Cancer, 2010, 127(12): 2870-2878. DOI: 10.1002/ijc.25289.

15.  王燕忠, 丁丽敏, 陈一瑞, 等. miRNA-21-5p对食管癌的诊断价值及其与STAT3的相关性研究[J]. 检验医学, 2020, 35(6): 531-534. DOI: 10.3969/j.issn.1673- 8640.2020.06.004. [Wang YZ, Ding LM, Chen YR, et al. Diag-nostic role of miRNA-21-5p for esophageal carcinoma and correlation of STAT3[J]. Laboratory Medi-cine, 2020, 35(6): 531-534.]

a).  Tanaka Y, Kamohara H, Kinoshita K, et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma[J]. Cancer, 2013, 119(6): 1159-1167. DOI: 10.1002/cncr.27895.

16.  Hirajima S, Komatsu S, Ichikawa D, et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma[J]. Br J Cancer, 2013, 108(9): 1822-1829. DOI: 10.1038/bjc.2013.148.

17.  Yao L, Zhang Y, Zhu Q, et al. Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion[J]. Int J Mol Med, 2015, 35(4): 1033-1041. DOI: 10.3892/ijmm.2015.2094.

18.  Lindner K, Borchardt C, Schopp M, et al. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miR-NAs in esophageal cancer[J]. J Exp Clin Cancer Res, 2014, 33(1): 73. DOI: 10.1186/s13046-014-0073-x.

19.  Li B, Hong P, Zheng C, et al. Identification of miR-29c and its target FBXO31 as a key regulatory mechanism in esophageal cancer chemoresistance: functional validation and clinical significance[J]. Theranostics, 2019, 9(6): 1599-1613. DOI: 10.7150/thno.30372.

20.  Chang ZW, Jia YX, Zhang WJ, et al. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1[J]. J Exp Clin Cancer Res, 2018, 37(1): 12-56.DOI: 10.1186/s13046-018-0724-4.

21.  Han L, Cui D, Li B, et al. MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esopha-geal squamous cell carcinoma cells by targeting Id-1[J].  Cancer Sci, 2019, 110(12): 3677-3688. DOI: 10.1111/cas.14220.

22.  Zhang K, Zhang B, Bai Y, et al. E2F1 promotes cancer cell sensitivity to cisplatin by regulating the cel-lular DNA damage response through miR-26b in esophageal squamous cell carcinoma[J]. J Cancer, 2020, 11(2): 301-310. DOI: 10.7150/jca.33983.

23.  Schoof CR, Botelho EL, Izzotti A, et al. MicroRNAs in cancer treatment and prognosis[J]. Am J Cancer Res, 2012, 2(4): 414-433.

24.  Wang P, Yang Z, Ye T, et al. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET[J]. J Exp Clin Cancer Res, 2020, 39(1): 7-12. DOI: 10.1186/s13046-019-1519-y.

25.  Liu J, Xue N, Guo Y, et al. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway[J]. Aging (Albany NY), 2019, 11(24): 12412-12427. DOI: 10.18632/aging.102580.

26.  Zhang Y, Chen W, Wang H, et al. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway[J]. Cancer Chemother Pharmacol, 2019, 84(6): 1209-1218. DOI: 10.1007/s00280-019-03922-2.

27.  Wang W, Guo C, Cui G, et al. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemo-therapy efficacy and prognosis in patients with esophageal squamous cell carcinoma[J]. World J Gas-troenterol, 2019, 25(37): 5604-5618. DOI: 10.3748/wjg.v25.i37.5604.

28.  Zhang HC, Tang KF. Clinical value of integrated-signature miRNAs in esophageal cancer[J]. Cancer Med, 2017, 6(8): 1893-1903. DOI: 10.1002/cam4.1129.

29.  Gao R, Wang Z, Liu Q, et al. MicroRNA-105 plays an independent prognostic role in esophageal can-cer and acts as an oncogene[J]. Cancer Biomark, 2020, 27(2): 173-180. DOI: 10.3233/CBM-180.

Popular Papers
© 2022 - 2026 Zhongnan Medical Journal Press of Zhongnan Hospital of Wuhan University|Support: Yufu Technology
About NM | Contact us